| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/28/2023 |
8-K
| Quarterly results |
| 08/21/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/09/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/27/2023 |
8-K
| Changes in Registrant's Certifying Accountant, Departure of Directors or Certain Officers; Election of Directors; Appointment... |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/05/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/02/2023 |
4
| Diamandis Peter (Director) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Exercised 429,037 options to buy
@ $0.57, valued at
$244.6k
Exercised 46,500 options to buy
@ $1.21, valued at
$56.3k
|
|
| 05/01/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/28/2023 |
3/A
| Smith James Alan (Director) has filed a Form 3/A on Vaxxinity, Inc. |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/28/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/28/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 04/05/2023 |
4
| Hu Mei Mei (See Remarks) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Granted 620,000 options to buy
@ $2.29, valued at
$1.4M
Granted 73,928 options to buy
@ $2.29, valued at
$169.3k
|
|
| 04/05/2023 |
4
| Reese Lou (See Remarks) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Granted 620,000 options to buy
@ $2.29, valued at
$1.4M
Granted 61,607 options to buy
@ $2.29, valued at
$141.1k
Granted 301,188 options to buy
@ $2.29, valued at
$689.7k
|
|
| 04/04/2023 |
4
| Pesile Jason (See Remarks) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Granted 32,700 options to buy
@ $2.29, valued at
$74.9k
|
|
| 04/04/2023 |
4
| Paula Molina Rene (See Remarks) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Granted 116,612 options to buy
@ $2.29, valued at
$267k
|
|
| 04/04/2023 |
4
| Palm Ulo (See Remarks) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Granted 123,418 options to buy
@ $2.29, valued at
$282.6k
|
|
| 03/27/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/27/2023 |
SC 13G/A
| Hu Mei Mei reports a 69.5% stake in Vaxxinity, Inc. |
| 01/27/2023 |
SC 13G/A
| UNITED BIOMEDICAL INC reports a 51.6% stake in Vaxxinity, Inc. |
| 01/25/2023 |
4
| Prime Movers Lab Fund I LP (10% Owner) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Sold 95,475 shares
@ $3.3514, valued at
$320k
Sold 405,217 shares
@ $3.3514, valued at
$1.4M
|
|
| 12/05/2022 |
4
| Prime Movers Lab Fund I LP (10% Owner) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Sold 63,843 shares
@ $2.9717, valued at
$189.7k
Sold 270,964 shares
@ $2.9717, valued at
$805.2k
Sold 2,620 shares
@ $2.5682, valued at
$6.7k
Sold 11,121 shares
@ $2.5682, valued at
$28.6k
|
|
|